Health
Special formulation of inhaled niclosamide may be effective against SARS-CoV-2 – News-Medical.Net
Now in new research published on the preprint server bioRxix*, a novel formulation of the drug Niclosamide (NIC) is observed to be effective against SARS-CoV-2 and MERS-CoV in mouse models; it also protects against methicillin-resistance Staphylococcus aureu…

Healthcare systems worldwide are overwhelmed by the raging COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As the current number of global infections of SARS-CoV-2 nears 33 million individuals, an effective treatment or vaccine option is crucial and desperately needed.
The SARS-CoV-2 virus is related to the earlier coronaviruses of SARS-CoV and the Middle East respiratory syndrome-related coronavirus (MERS-CoV). Now in new research published on the pre…
-
Noosa News19 hours ago
How Lily Steele-Park took her rapist to court and won
-
Business22 hours ago
5 things to watch on the ASX 200 on Tuesday 8 July 2025
-
Business24 hours ago
Where will Nvidia stock be in 1 year?
-
General23 hours ago
Aboriginal policy vacuum from Liberals, Labor as NAIDOC Week starts